UniProt ID | AL3A1_HUMAN | |
---|---|---|
UniProt AC | P30838 | |
Protein Name | Aldehyde dehydrogenase, dimeric NADP-preferring | |
Gene Name | ALDH3A1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 453 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde (Probable). They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation (Probable). Oxidizes medium and long chain aldehydes into non-toxic fatty acids. [PubMed: 1737758 Preferentially oxidizes aromatic aldehyde substrates] | |
Protein Sequence | MSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAYYEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNLTIQPMVGAIAAGNSVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKERFDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNSGQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEGQKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREKPLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFETFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSKISEAVK ------CCHHHHHHH | 38.40 | 20068231 | |
2 | Acetylation | ------MSKISEAVK ------CCHHHHHHH | 38.40 | 22814378 | |
3 | Acetylation | -----MSKISEAVKR -----CCHHHHHHHH | 49.29 | 19608861 | |
5 | Phosphorylation | ---MSKISEAVKRAR ---CCHHHHHHHHHH | 24.20 | 22496350 | |
163 | Phosphorylation | QYLDKDLYPVINGGV HHHCCCCHHHHCCCC | 12.94 | 110743635 | |
178 | Acetylation | PETTELLKERFDHIL CCHHHHHHHHCCEEE | 60.51 | 19608861 | |
178 | Ubiquitination | PETTELLKERFDHIL CCHHHHHHHHCCEEE | 60.51 | 19608861 | |
186 | Phosphorylation | ERFDHILYTGSTGVG HHCCEEEEECCCCHH | 14.41 | 71735 | |
194 | Acetylation | TGSTGVGKIIMTAAA ECCCCHHHHHHHHHH | 27.01 | 19608861 | |
198 | Phosphorylation | GVGKIIMTAAAKHLT CHHHHHHHHHHHHCC | 11.61 | 110743641 | |
202 | Acetylation | IIMTAAAKHLTPVTL HHHHHHHHHCCCEEE | 34.13 | 25825284 | |
205 | Phosphorylation | TAAAKHLTPVTLELG HHHHHHCCCEEEEEC | 18.55 | 110743647 | |
208 | Phosphorylation | AKHLTPVTLELGGKS HHHCCCEEEEECCCC | 18.73 | 22817900 | |
214 | Ubiquitination | VTLELGGKSPCYVDK EEEEECCCCCCCCCC | 49.80 | - | |
221 | Ubiquitination | KSPCYVDKNCDLDVA CCCCCCCCCCCCCHH | 49.81 | - | |
269 | Ubiquitination | EKLKKSLKEFYGEDA HHHHHHHHHHHCCHH | 53.52 | 19608861 | |
269 | Acetylation | EKLKKSLKEFYGEDA HHHHHHHHHHHCCHH | 53.52 | 19608861 | |
272 | Phosphorylation | KKSLKEFYGEDAKKS HHHHHHHHCCHHHHH | 22.24 | 110743653 | |
277 | Ubiquitination | EFYGEDAKKSRDYGR HHHCCHHHHHCCHHH | 64.70 | - | |
287 | Phosphorylation | RDYGRIISARHFQRV CCHHHHHCHHHHHHH | 19.51 | 24719451 | |
302 | Ubiquitination | MGLIEGQKVAYGGTG HHHHCCEEEECCCCC | 39.42 | - | |
305 | Phosphorylation | IEGQKVAYGGTGDAA HCCEEEECCCCCCHH | 21.05 | 18083107 | |
399 | Phosphorylation | IVHITLHSLPFGGVG EEEEEEECCCCCCCC | 40.63 | 46162019 | |
427 | Phosphorylation | ETFSHRRSCLVRPLM CCCCCCCCEEEEECC | 16.26 | 28188228 | |
443 | Phosphorylation | DEGLKVRYPPSPAKM CCCCCEECCCCCCCC | 23.60 | 29396449 | |
446 | Phosphorylation | LKVRYPPSPAKMTQH CCEECCCCCCCCCCC | 32.74 | 27422710 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AL3A1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AL3A1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRF_HUMAN | SRF | physical | 21988832 | |
CYHR1_HUMAN | CYHR1 | physical | 21988832 | |
FXL12_HUMAN | FBXL12 | physical | 26124079 | |
ZN446_HUMAN | ZNF446 | physical | 28514442 | |
AL3A2_HUMAN | ALDH3A2 | physical | 28514442 | |
IGLL5_HUMAN | IGLL5 | physical | 28514442 | |
H2A2C_HUMAN | HIST2H2AC | physical | 28514442 | |
RCCD1_HUMAN | RCCD1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3; LYS-178; LYS-194 ANDLYS-269, AND MASS SPECTROMETRY. |